Title: Full Text of HB4154
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB4154 ILGA.GOV HB4154 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB4154 Introduced 10/15/2025, by Rep. Natalie A. Manley SYNOPSIS AS INTRODUCED: 225 ILCS 85/7  from Ch. 111, par. 4127    Amends the Pharmacy Practice Act. Provides that the Department of Financial and Professional Regulation shall authorize the examination of applicants as pharmacists at such times and places as it may determine (rather than not less than 3 times per year). Provides that the Department and the Board of Pharmacy shall regularly monitor the North American Pharmacist Licensure Examination or its successor to ensure that the examination of applicants is of a character to give a fair test of the qualifications of the applicant to practice pharmacy. Provides that applicants for examination as pharmacists for the calendar years 2025, 2026, and 2027 shall be required to pass only the North American Pharmacist Licensure Examination. Provides that the results from the Multistate Pharmacy Jurisprudence Examination for such applicants shall be disregarded and shall not prohibit an applicant who has successfully passed the North American Pharmacist Licensure Examination from engaging in the practice of pharmacy. Provides that applicants for examination as pharmacists shall be required to pay, either to the Department or the National Association of Boards of Pharmacy (rather than the designated testing service), a fee covering the cost of providing the examination. Provides that the Department shall notify applicants taking the examination of their results no later than 2 weeks after (rather than within 7 weeks of) the examination date. Makes conforming changes.LRB104 15658 AAS 28830 b  A BILL FOR HB4154LRB104 15658 AAS 28830 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Pharmacy Practice Act is amended by 5changing Section 7 as follows: 6    (225 ILCS 85/7)  (from Ch. 111, par. 4127)7    (Section scheduled to be repealed on January 1, 2028)8    Sec. 7. Application; examination. Applications for 9original licenses shall be made to the Department in writing 10or electronically on forms prescribed by the Department and 11shall be accompanied by the required fee, which shall not be 12refundable. Any such application shall require such 13information as in the judgment of the Department will enable 14the Board and Department to pass on the qualifications of the 15applicant for a license.16    The Department shall authorize the examination 17examinations of applicants as pharmacists not less than 3 18times per year at such times and places as it may determine. 19The North American Pharmacist Licensure Examination (NAPLEX) 20or its successor shall be monitored regularly by the 21Department and the Board of Pharmacy to ensure that the 22examination of applicants is shall be of a character to give a 23fair test of the qualifications of the applicant to practice   HB4154- 2 -LRB104 15658 AAS 28830 b1pharmacy.2    Applicants for examination as pharmacists for the calendar 3years 2025, 2026, and 2027 shall be required to pass only the 4North American Pharmacist Licensure Examination. The results 5from the Multistate Pharmacy Jurisprudence Examination (MPJE) 6for such applicants shall be disregarded and shall not 7prohibit an applicant who has successfully passed the North 8American Pharmacist Licensure Examination from engaging in the 9practice of pharmacy. 10    Applicants for examination as pharmacists shall be 11required to pay, either to the Department or the National 12Association of Boards of Pharmacy designated testing service, 13a fee covering the cost of providing the examination. Failure 14to appear for the examination on the scheduled date, at the 15time and place specified, after the applicant's application 16for examination has been received and acknowledged by the 17Department or the National Association of Boards of Pharmacy 18designated testing service, shall result in the forfeiture of 19the examination fee. The examination shall be developed and 20provided by the National Association of Boards of Pharmacy.21    If an applicant neglects, fails, or refuses to take the an 22examination or fails to pass the an examination for a license 23under this Act within 3 years after filing his application, 24the application is denied. However, such applicant may 25thereafter make a new application accompanied by the required 26fee and show evidence of meeting the requirements in force at   HB4154- 3 -LRB104 15658 AAS 28830 b1the time of the new application.2    The Department shall notify applicants taking the 3examination of their results no later than 2 weeks after 4within 7 weeks of the examination date. Further, the 5Department shall have the authority to immediately authorize 6such applicants who successfully pass the examination to 7engage in the practice of pharmacy.8    An applicant shall have one year from the date of 9notification of successful completion of the examination to 10apply to the Department for a license. If an applicant fails to 11make such application within one year, the applicant shall be 12required to again take and pass the examination.13    An applicant who has graduated with a professional degree 14from a school of pharmacy located outside of the United States 15must do the following:16        (1) obtain a Foreign Pharmacy Graduate Examination 17    Committee (FPGEC) Certificate;18        (2) complete 1,200 hours of clinical training and 19    experience, as defined by rule, in the United States or 20    its territories; and21        (3) successfully complete the licensing requirements 22    set forth in Section 6 of this Act, as well as those 23    adopted by the Department by rule. 24    The Department may employ consultants for the purpose of 25preparing and conducting examinations.26(Source: P.A. 100-497, eff. 9-8-17.)


================================================================================

Raw Text:
Full Text of HB4154 ILGA.GOV HB4154 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB4154 Introduced 10/15/2025, by Rep. Natalie A. Manley SYNOPSIS AS INTRODUCED: 225 ILCS 85/7  from Ch. 111, par. 4127    Amends the Pharmacy Practice Act. Provides that the Department of Financial and Professional Regulation shall authorize the examination of applicants as pharmacists at such times and places as it may determine (rather than not less than 3 times per year). Provides that the Department and the Board of Pharmacy shall regularly monitor the North American Pharmacist Licensure Examination or its successor to ensure that the examination of applicants is of a character to give a fair test of the qualifications of the applicant to practice pharmacy. Provides that applicants for examination as pharmacists for the calendar years 2025, 2026, and 2027 shall be required to pass only the North American Pharmacist Licensure Examination. Provides that the results from the Multistate Pharmacy Jurisprudence Examination for such applicants shall be disregarded and shall not prohibit an applicant who has successfully passed the North American Pharmacist Licensure Examination from engaging in the practice of pharmacy. Provides that applicants for examination as pharmacists shall be required to pay, either to the Department or the National Association of Boards of Pharmacy (rather than the designated testing service), a fee covering the cost of providing the examination. Provides that the Department shall notify applicants taking the examination of their results no later than 2 weeks after (rather than within 7 weeks of) the examination date. Makes conforming changes.LRB104 15658 AAS 28830 b  A BILL FOR HB4154LRB104 15658 AAS 28830 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Pharmacy Practice Act is amended by 5changing Section 7 as follows: 6    (225 ILCS 85/7)  (from Ch. 111, par. 4127)7    (Section scheduled to be repealed on January 1, 2028)8    Sec. 7. Application; examination. Applications for 9original licenses shall be made to the Department in writing 10or electronically on forms prescribed by the Department and 11shall be accompanied by the required fee, which shall not be 12refundable. Any such application shall require such 13information as in the judgment of the Department will enable 14the Board and Department to pass on the qualifications of the 15applicant for a license.16    The Department shall authorize the examination 17examinations of applicants as pharmacists not less than 3 18times per year at such times and places as it may determine. 19The North American Pharmacist Licensure Examination (NAPLEX) 20or its successor shall be monitored regularly by the 21Department and the Board of Pharmacy to ensure that the 22examination of applicants is shall be of a character to give a 23fair test of the qualifications of the applicant to practice   HB4154- 2 -LRB104 15658 AAS 28830 b1pharmacy.2    Applicants for examination as pharmacists for the calendar 3years 2025, 2026, and 2027 shall be required to pass only the 4North American Pharmacist Licensure Examination. The results 5from the Multistate Pharmacy Jurisprudence Examination (MPJE) 6for such applicants shall be disregarded and shall not 7prohibit an applicant who has successfully passed the North 8American Pharmacist Licensure Examination from engaging in the 9practice of pharmacy. 10    Applicants for examination as pharmacists shall be 11required to pay, either to the Department or the National 12Association of Boards of Pharmacy designated testing service, 13a fee covering the cost of providing the examination. Failure 14to appear for the examination on the scheduled date, at the 15time and place specified, after the applicant's application 16for examination has been received and acknowledged by the 17Department or the National Association of Boards of Pharmacy 18designated testing service, shall result in the forfeiture of 19the examination fee. The examination shall be developed and 20provided by the National Association of Boards of Pharmacy.21    If an applicant neglects, fails, or refuses to take the an 22examination or fails to pass the an examination for a license 23under this Act within 3 years after filing his application, 24the application is denied. However, such applicant may 25thereafter make a new application accompanied by the required 26fee and show evidence of meeting the requirements in force at   HB4154- 3 -LRB104 15658 AAS 28830 b1the time of the new application.2    The Department shall notify applicants taking the 3examination of their results no later than 2 weeks after 4within 7 weeks of the examination date. Further, the 5Department shall have the authority to immediately authorize 6such applicants who successfully pass the examination to 7engage in the practice of pharmacy.8    An applicant shall have one year from the date of 9notification of successful completion of the examination to 10apply to the Department for a license. If an applicant fails to 11make such application within one year, the applicant shall be 12required to again take and pass the examination.13    An applicant who has graduated with a professional degree 14from a school of pharmacy located outside of the United States 15must do the following:16        (1) obtain a Foreign Pharmacy Graduate Examination 17    Committee (FPGEC) Certificate;18        (2) complete 1,200 hours of clinical training and 19    experience, as defined by rule, in the United States or 20    its territories; and21        (3) successfully complete the licensing requirements 22    set forth in Section 6 of this Act, as well as those 23    adopted by the Department by rule. 24    The Department may employ consultants for the purpose of 25preparing and conducting examinations.26(Source: P.A. 100-497, eff. 9-8-17.)